Umbilical cord derived mesenchymal stem cell therapy (Cytopeutics)

N/A

Report date: 2023/11/14 20:00:32

Base Information

Drug NameUmbilical cord derived mesenchymal stem cell therapy (Cytopeutics)

Drug Alias NameCyto-MSCNeuroncell-EXUCMSCs therapy (Cytopeutics)Umbilical Cord Mesenchymal Stem Cells therapy (Cytopeutics)Cytopeutics

ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapyCell and gene therapy > Cell therapy > Source of cells > Umbilical cord-derived

Mechanisms of ActionStem cell replacements

TargetsNot applicable

Therapy Area/IndicationsIschemic StrokeGraft vs Host DiseaseStroke

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland ChinaMalaysia

CombinationsNo

Global Highest StatusPhase 3 Clinical

Highest Status in ChinaIND

Originator CompaniesCytopeutics Sdn Bhd

China Registration ClassN/A

Develop Information

Active CompaniesCytopeutics Sdn Bhd

Inactive CompaniesN/A

Active IndicationsIschemic StrokeGraft vs Host DiseaseStroke

Inactive IndicationsN/A

Other Information

ATC CodeN/A